gallocatechol has been researched along with HTLV-I Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abou-Khouzam, R; Al-Hejin, A; Azar, R; Barbour, E; Damanhouri, GA; Diab-Assaf, M; Harakeh, S; Kumosani, T; Niedzwiecki, A; Rath, M | 1 |
1 other study(ies) available for gallocatechol and HTLV-I Infections
| Article | Year |
|---|---|
Effects of nutrients on matrix metalloproteinases in human T-lymphotropic virus type 1 positive and negative malignant T-lymphocytes.
Topics: Ascorbic Acid; Catechin; Drug Synergism; Gene Expression Regulation, Neoplastic; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Leukemia, T-Cell; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Protein Biosynthesis; Transcription, Genetic | 2014 |